Mi az ára MetaStat Inc (MTST)

MetaStat Inc (MTST) ára $0.001

Mi a MetaStat Inc (MTST piaci tőkésítése)

MetaStat Inc piaci tőkésítése (MTST) $5.88K

MetaStat Inc (MTST) Nyereség

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.

Év	Nyereség	Változtassa meg
Nincs elég adat a megadott dátumokhoz.

Év

Nyereség

Változtassa meg

Nincs elég adat a megadott dátumokhoz.

Vállalat	Nyereség	Nyereségkülönbség	Ország
Contemporary Amperex Technology Co., Limited 300750.SZ	-	-	CN
ABB Ltd ABBN.SW	-	-	CH
Eaton Corporation plc ETN.US	$4.83B	-	IE
Vertiv Holdings Co VRT.US	$2.11B	-	US
Delta Electronics (Thailand) Public Company Limited DELTA.BK	-	-	TH

Vállalat

Nyereség

Nyereségkülönbség

Ország